p53 antibodies in patients with various types of cancer: assay, identification, and characterization.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Clinical Cancer Research

• Publication date

  1995-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9815945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum p53 antibodies as early markers of lung cancer

  1995cited by this paper
• Absence of p53 autoantibodies in a significant proportion of breast cancer patients.

  1995cited by this paper
• Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

  1995cited by this paper
• Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.

  1995cited by this paper
• p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumour tissue

  1995cited by this paper
• Detection of the anti-p53 antibody response in malignant and benign pancreatic disease.

  1994cited by this paper
• The relationship between serum p53 autoantibodies and characteristics of human breast cancer.

  1994cited by this paper
• Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.

  1994cited by this paper
• Linear antigenic sites defined by the B-cell response to human p53 are localized predominantly in the amino and carboxy-termini of the protein.

  1994cited by this paper
• Multifactorial analysis of p53 alteration in human cancer: A review

  1994cited by this paper
• Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.

  1994cited by this paper
• Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers

  1994cited by this paper
• Prognostic significance of TP53 alterations in breast carcinoma.

  1993cited by this paper
• Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface.

  1993cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of the α‐fetoprotein status

  1993cited by this paper
• TP53 tumor suppressor gene: A model for investigating human mutagenesis

  1992cited by this paper
• Increased p53 protein content of colorectal tumours correlates with poor survival.

  1992cited by this paper
• Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

  1992cited by this paper
• Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study.

  1992cited by this paper
• Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

  1992cited by this paper
• Prognostic significance of p53 overexpression in gastric and colorectal carcinoma.

  1992cited by this paper
• The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

  1992cited by this paper
• Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers.

  1992cited by this paper
• Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

  1992cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Evolutionary conservation of the biochemical properties of p53: specific interaction of Xenopus laevis p53 with simian virus 40 large T antigen and mammalian heat shock proteins 70

  1989cited by this paper
• Presence of circulating antibodies against cellular protein p53 in a notable proportion of children with B‐cell lymphoma

  1987cited by this paper
• Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

  1982cited by this paper
• Abelson murine leukemia virus-induced tumors elicit antibodies against a host cell protein, P50

  1980cited by this paper
• Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse.

  1979cited by this paper
• Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum

  1979cited by this paper
• Cáncer

  1939cited by this paper

• Redefining serological diagnostics with immunoaffinity proteomics

  2023cites this paper
• Isotypic analysis of anti-p53 serum autoantibodies and p53 protein tissue phenotypes in colorectal cancer.

  2022cites this paper
• p53 Antibodies as a Diagnostic Marker for Cancer: Results from a Meta-Analysis

  2021cites this paper
• ENZYME-LINKED IMMUNOSORBENT ASSAY DETECTION FOR MALIGNANCY USING ANTI-P53 ANTIBODIES

  2021cites this paper
• Re-evaluating the clinical significance of serum p53 antibody levels in patients with oral cancer in Japanese clinical practice

  2021cites this paper
• Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer

  2021cites this paper
• Serum p53 antibodies detection in oral squamous cell carcinoma, oral potentially malignant disorders and healthy individuals: A multicentre study.

  2021cites this paper
• Immunotherapy Advances for Epithelial Ovarian Cancer

  2020cites this paper
• Anti‐p53 autoantibody in blood as a diagnostic biomarker for colorectal cancer: A meta‐analysis

  2020cites this paper
• Mutant p53 as an Antigen in Cancer Immunotherapy

  2020cites this paper
• Serum anti-p53 autoantibodies in angiosarcoma.

  2020cites this paper
• Diagnostic Value of Autoantibodies in Lung Cancer: a Systematic Review and Meta-Analysis

  2018cites this paper
• Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.

  2017cites this paper
• A Platform for Interrogating Cancer-Associated p53 Alleles

  2016cites this paper
• Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Colorectal Cancer.

  2016cites this paper
• The clinical translational potential of p53-related alterations as cancer biomarkers.

  2015cites this paper
• Proteomic profiling of antigens in circulating immune complexes associated with each of seven autoimmune diseases.

  2015cites this paper
• Colorectal Cancer Circulating Biomarkers

  2015cites this paper
• Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-Analysis

  2015cites this paper
• Autoantibodies to p 53 in Sera of Patients with Autoimmune Thyroid Disease

  2015cites this paper
• Diagnostic relevance of autoantibody detection against inhibitors of apoptosis proteins in colon cancer and colon adenoma.

  2015cites this paper
• A novel algorithm to improve specificity in ovarian cancer detection.

  2015cites this paper
• Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

  2015cites this paper
• The Significance of Combined Measurement of p53 Antibody and other Tumor Markers for Colorectal Cancer after Curative Resection.

  2015cites this paper
• p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up

  2014cites this paper
• Rapid and Sensitive Detection of p53 Based on DNA-Protein Binding Interactions Using Silver Nanoparticle Films and Microwave Heating.

  2014cites this paper
• Journal of Biotechnology Research Center (Special edition) Vol. 8 No. 1

  2014cites this paper
• Comparison of the Diagnostic Accuracy of Three Com- mercially Available Enzyme Immunoassays for Anti-p53

  2014cites this paper
• Secreted recombinant P53 protein from Pichia pastoris is a useful antigen for detection of serum p53: autoantibody in patients with advanced colorectal adenocarcinoma

  2013cites this paper
• Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers

  2013cites this paper
• NY-ESO-1 antibody as a novel tumour marker of gastric cancer

  2013cites this paper
• Prognostic utility of autoantibodies to α‐enolase and Hsp70 for cancer of the gingivo‐buccal complex using immunoproteomics

  2013cites this paper
• Immune complexome analysis.

  2013cites this paper
• Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer

  2013cites this paper
• Le dépistage du futur du cancer broncho-pulmonaire : perspectives et mythes

  2013cites this paper
• Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy

  2012cites this paper
• Autoantibodies against insulin-like growth factor-binding protein-2 as a serological biomarker in the diagnosis of lung cancer

  2012cites this paper
• Biological Therapy of Breast Cancer

  2012cites this paper
• Antigen-specific immunotherapy in ovarian cancer and p53 as tumor antigen.

  2012cites this paper
• Autoimmunity and cancer.

  2012cites this paper
• Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis.

  2011cites this paper
• Wildtype p53-specific Antibody and T-Cell Responses in Cancer Patients

  2011influential citation
• Osteopontin is a tumor autoantigen in prostate cancer patients.

  2011cites this paper
• Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies

  2011cites this paper
• Slina – dijagnostički medij za rano otkrivanje bolesti

  2011cites this paper
• Prognostic and Diagnostic Value of Spontaneous Tumor-Related Antibodies

  2010cites this paper
• leukemia Immunity to WT1 in the animal model and in patients with acute myeloid

  2010cites this paper
• Development of a Multiplexed Tumor-Associated Autoantibody-Based Blood Test for the Detection of Non–Small Cell Lung Cancer

  2010cites this paper
• Saliva: Physiology and Diagnostic Potential in Health and Disease

  2010cites this paper
• Autoantibodies against tumor-related antigens: incidence and biologic significance.

  2010cites this paper
• Anti-p53 antibodies in serum: relationship to tumor biology and prognosis of breast cancer patients

  2010cites this paper
• Are Paradoxical Cell Cycle Activities in Neurons and Glia Related to the Metabolic Theory of Alzheimer's Disease?

  2010cites this paper
• Serum p53 Antibody as Tumor Marker for Follow-Up of Colorectal Cancer After Curative Resection

  2009cites this paper
• Current opinions concerning the restoration of endodontically treated teeth: basic principles

  2009cites this paper
• A systematic review of humoral immune responses against tumor antigens

  2009cites this paper
• Immunohistochemical Detection of p53 and Serum Anti p53 Antibodies from Gastric Cancer Patients in Thailand

  2009cites this paper
• Molecular and immunological aspects of p53 and p53-autoantibodies in head and neck squamous cell carcinoma.

  2009cites this paper
• Anti-p53 autoantibody in systemic sclerosis: association with limited cutaneous systemic sclerosis.

  2008cites this paper
• Serum Anti-p53 Antibodies as a useful Marker for Prognosis of Gastric Carcinoma

  2007cites this paper
• Serum anti-p53 antibodies as a useful marker for prognosis of gastric carcinoma.

  2007cites this paper
• Titration of Serum p53 Autoantibodies in Patients with Colorectal Cancer and the Clinical Significance of Post-operative Monitoring

  2007cites this paper
• Clinical significance of serum p53 antibodies in patients with ulcerative colitis and its carcinogenesis

  2007cites this paper
• A highly sensitive particle agglutination assay for the detection of P53 autoantibodies in patients with lung cancer

  2007cites this paper
• Analysis of p53 Gene Alterations in Cancer: A Critical View

  2007cites this paper
• Analyse de la rupture de tolérance vis-à-vis de la p53 dans le cancer du sein en Tunisie

  2006cites this paper
• Detection of Serum Anti-Extracellular Protein Kinase a Autoantibodies as a Potential Tumor Marker

  2006cites this paper
• Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.

  2006cites this paper
• Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.

  2005cites this paper
• The Presence of Serum Anti-p53 Antibodies from Patients with Invasive Ductal Carcinoma of Breast: Correlation to Other Clinical and Biological Parameters

  2005cites this paper
• Titration of serum p53 antibodies in patients with gastric cancer: a single-institute study of 40 patients

  2005cites this paper
• Chapter 12 ANALISYS OF P 53 GENE AALTERATIONS IN CANCER : A CRITICAL VIEW

  2005influential citation
• Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy

  2004cites this paper
• WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies

  2003cites this paper
• Radiosensitivity in lung cancer with focus on p53: a review based on a doctoral thesis.

  2003cites this paper
• Serum p53 antibodies in correlation to other biological parameters of breast cancer.

  2003cites this paper
• Vaccination of patients with solid tumours.

  2003cites this paper
• THE DEVELOPMENT OF A NEW TUMOR MARKER “p53 IgG ANTIBODIES”

  2003cites this paper
• Serum p53 antibodies in patients with lung cancer: correlation with clinicopathologic features and smoking.

  2003cites this paper
• New ELISA technique for analysis of p53 protein/DNA binding properties.

  2002cites this paper
• Clinical relevance of molecular markers in lung cancer.

  2002cites this paper
• Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responses.

  2002cites this paper
• Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.

  2002cites this paper
• Cancer genetics and tumor antigens: time for a combined view?

  2002cites this paper
• Generation of scFv from a phage display mini-library derived from tumor-infiltrating B-cells.

  2002cites this paper
• The diagnostic applications of saliva--a review.

  2002cites this paper
• Expression and immunogenicity of a tumor‐associated antigen, 90K/Mac‐2 binding protein, in lung carcinoma

  2002cites this paper
• Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides.

  2002cites this paper
• T H E DIAGNOSTI C APPLICATION SO F S ALIV A — A REVIEW

  2002cites this paper
• Detection of p73 antibodies in patients with various types of cancer: immunological characterization

  2001influential citation
• Circulating anti-p53 antibodies in esophageal cancer patients.

  2001cites this paper
• Long lasting p53‐specific T cell memory responses in the absence of anti‐p53 antibodies in patients with resected primary colorectal cancer

  2001cites this paper
• Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.

  2001cites this paper
• New molecular approaches to lung cancer: biological and clinical implications of P53, P16 and K-RAS studies.

  2001cites this paper
• p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression

  2001influential citation
• G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview.

  2001cites this paper
• Clinical significance of p53 antigen and anti-p53 antibodies in the sera of hepatocellular carcinoma patients

  2001cites this paper
• Prognostic value of serum biological markers in patients with hepatocellular carcinoma.

  2001cites this paper
• Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance.

  2001cites this paper
• Prognostic Value of Serum Biological Markers in Patients with Hepatocellular Carcinoma 1

  2001cites this paper
• Auto-anticorps anti-p53 et marqueurs sériques, NSE et CYFRA 21-1, dans le cadre des cancers broncho-pulmonaires

  2001cites this paper